MiR-342 was shown to be a negative regulator of E2F1 affecting MYC expression in lung cancer cells [36] and also negatively regulate FOXM1 and FOXQ1 expression in colorectal cancer cells [37]. Here, E2F1 is linked to lung carcinoma.